My SciELO
Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in SciELO
Similars in Google
Share
Revista Clínica de Medicina de Familia
On-line version ISSN 2386-8201Print version ISSN 1699-695X
Abstract
RUBIO-LOPEZ, Juan María. Hallucinations after treatment in a patient with Parkinson's. Rev Clin Med Fam [online]. 2023, vol.16, n.1, pp.58-60. Epub Apr 17, 2023. ISSN 2386-8201. https://dx.doi.org/10.55783/rcmf.160110.
Parkinson's Disease (PD) can be deemed the second neurodegenerative disease in terms of prevalence. PD is a chronic disease that evolves in consecutive phases, with an insidious initial diagnosis and complex management for the primary care physician. In this paper we report a case of a poorly studied drug interaction between antidepressant and antiparkinsonian drugs. The patient went to a neurology review where, in a medication adjustment made by a neurology colleague, Rasalagin was added to her usual treatment (levodopa/carbidopa), which created hallucinations in the patient. After a minor case study, the conclusion was drawn that rasalagin should be withdrawn and the neurological picture of hallucinations remitted.
Keywords : Depression; Drug Interactions; Hallucinations; Parkinson's Disease.